U.S. markets open in 6 hours 56 minutes

Aptose Biosciences Inc. (APTO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7700-0.0600 (-1.24%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/12/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
428.71M530.44M389.64M527.77M476.52M440.99M
Enterprise Value 3
317.58M409.12M258.11M446.35M387.95M344.92M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
3.934.473.016.735.524.82
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-5.33-25.41-17.67-33.97-24.66-29.54

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-37.11%
S&P500 52-Week Change 345.56%
52 Week High 38.4800
52 Week Low 33.3900
50-Day Moving Average 35.3750
200-Day Moving Average 34.7815

Share Statistics

Avg Vol (3 month) 34.45M
Avg Vol (10 day) 31.01M
Shares Outstanding 588.94M
Implied Shares Outstanding 6N/A
Float 69.11M
% Held by Insiders 14.61%
% Held by Institutions 154.60%
Shares Short (Apr 29, 2021) 43.36M
Short Ratio (Apr 29, 2021) 42.5
Short % of Float (Apr 29, 2021) 43.81%
Short % of Shares Outstanding (Apr 29, 2021) 43.77%
Shares Short (prior month Mar 30, 2021) 44.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.21%
Return on Equity (ttm)-60.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -60.04M
Net Income Avi to Common (ttm)-59.94M
Diluted EPS (ttm)-0.7050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.08M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)950k
Total Debt/Equity (mrq)0.87
Current Ratio (mrq)21.26
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-36.16M
Levered Free Cash Flow (ttm)-15.77M